- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Estrogen Receptor-positive Breast Cancer
Total 12155 results
-
Dana-Farber Cancer InstituteJohns Hopkins University; National Cancer Institute (NCI); Gateway for Cancer... and other collaboratorsRecruitingBreast Cancer | Metastatic Breast Cancer | HER2-positive Breast CancerUnited States
-
Fudan UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
Korean Cancer Study GroupUnknownPhase II Study of Herzuma® Plus Gedatolisib in Patients With HER-2 Positive Metastatic Breast CancerMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
University of MiamiRecruitingBreast Cancer | Metastatic Breast Cancer | ER-positive Breast Cancer | HER2-negative Breast CancerUnited States
-
Centre Leon BerardAmgenRecruitingHER2-positive Breast Cancer | Operable Breast CancerFrance
-
Bolt Biotherapeutics, Inc.Hoffmann-La RocheActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerSpain, United States, Italy
-
National Cancer Center, KoreaActive, not recruitingMetastatic Breast Cancer | HER2-positive Breast CancerKorea, Republic of
-
Jinming YuJiangsu HengRui Medicine Co., Ltd.UnknownMetastatic Breast Cancer | HER2-positive Breast CancerChina
-
Fondazione Sandro PitiglianiClinical Research Technology S.r.l.RecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerItaly
-
Imperial College LondonMedical Research Council; ECMCRecruitingMetastatic Breast Cancer | HER2-negative Breast Cancer | ER Positive Breast CancerUnited Kingdom
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyTerminatedBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | HER2/Neu-positive Breast CancerUnited States
-
Infinity Pharmaceuticals, Inc.TerminatedBreast Cancer | Metastatic Breast Cancer | HER2 Positive Breast Cancer | Cancer of the BreastUnited States, Spain
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)SuspendedAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Invasive Breast Carcinoma | Hormone Receptor Positive Breast Carcinoma | Breast Ductal Carcinoma in Situ | HER2 Negative Breast CarcinomaUnited States
-
AstraZenecaDaiichi SankyoRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | Unresectable Breast Cancer | HER2-low Expressing Breast CancerCanada
-
University of Kansas Medical CenterPfizerTerminatedHER2-positive Breast Cancer | Breast Cancer MetastaticUnited States
-
Amsterdam UMC, location VUmcAstraZenecaRecruitingBreast Cancer | Gastric Cancer | Metastatic Breast Cancer | HER2-positive Breast Cancer | HER2-positive Gastric Cancer | Metastatic Gastric CancerNetherlands
-
Dana-Farber Cancer InstituteMacroGenics; Translational Breast Cancer Research ConsortiumActive, not recruitingBreast Cancer | HER2-positive Breast Cancer | Stage II Breast Cancer | Stage III Breast CancerUnited States
-
Sichuan Baili Pharmaceutical Co., Ltd.Baili-Bio (Chengdu) Pharmaceutical Co., Ltd.Not yet recruiting
-
University of Illinois at ChicagoRecruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
The Netherlands Cancer InstituteAstraZeneca; Daiichi SankyoRecruiting
-
Case Comprehensive Cancer CenterNot yet recruitingNode-positive Breast Cancer
-
Henan Cancer HospitalRecruitingBreast Cancer | HER2-positive Breast CancerChina
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
NRG OncologyNational Cancer Institute (NCI); Alliance for Clinical Trials in Oncology; Eastern... and other collaboratorsRecruitingHER2-positive Breast CancerUnited States, Puerto Rico
-
First Affiliated Hospital Xi'an Jiaotong UniversityRecruitingHER2-positive Breast CancerChina
-
Institut de cancérologie Strasbourg EuropeNot yet recruitingProtocol for Herceptin as Adjuvant Therapy With Reduced Exposure to Chemotherapy (PHARE-C) (PHARE-C)HER2-positive Breast Cancer
-
Peking UniversityRecruitingHER2-positive Breast CancerChina
-
University of Alabama at BirminghamRecruitingHER2-positive Breast CancerUnited States
-
King's College LondonGuy's and St Thomas' NHS Foundation Trust; Brighton and Sussex University Hospitals...Recruiting
-
xuexin heNot yet recruitingHER2-positive Breast Cancer
-
University of Texas Southwestern Medical CenterMerck Sharp & Dohme LLC; Breast Cancer Research FoundationActive, not recruitingBreast Cancer | HER2-positive Breast CancerUnited States
-
Seagen Inc.Active, not recruitingHER2 Positive Breast CancerUnited States
-
Fox Chase Cancer CenterGenentech, Inc.Active, not recruitingHER2-positive Breast CancerUnited States
-
Zhejiang Hisun Pharmaceutical Co. Ltd.Completed
-
Fondazione Policlinico Universitario Agostino Gemelli...Active, not recruiting
-
Alteogen, Inc.CompletedHER2-positive Breast CancerKorea, Republic of
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingHER2-positive Breast CancerChina
-
Biyun Wang, MDCompleted
-
Guangdong Provincial People's HospitalCompletedHER2-Positive Breast CancerChina
-
Sun Yat-sen UniversityCompletedHER2 Positive Breast CancerChina
-
Yale UniversityGenentech, Inc.CompletedHer2-Positive Breast CancerUnited States
-
Guangdong Provincial People's HospitalUnknownHER2-Positive Breast CancerChina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityUnknownHER2-positive Breast Cancer
-
Shandong UniversityUnknownHER2-positive Breast Cancer
-
Vlaamse Vereniging voor Obstetrie en GynaecologieCompletedER-positive Breast CancerBelgium
-
Fundacio Clinic BarcelonaUniversity of Padova; Sheba Medical Center; Istituto Oncologico Veneto IRCCS; University... and other collaboratorsNot yet recruitingHER2-positive Breast Cancer | Early-stage Breast Cancer
-
Roswell Park Cancer InstituteCompletedNode Negative Breast Cancer | Node Positive Breast Cancer
-
Renske AltenaTerminatedHER2-positive Breast Cancer | Early-stage Breast CancerSweden
-
Peking Union Medical College HospitalRecruitingHER2-positive Breast Cancer | Early-stage Breast CancerChina
-
Yonsei UniversityRecruitingMetastatic Breast Cancer | HER2-positive Breast Cancer | PostmenopausalKorea, Republic of